The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons
暂无分享,去创建一个
[1] P. Holmans,et al. Allowing for Genotyping Error in Analysis of Unmatched Case‐Control Studies , 2003, Annals of human genetics.
[2] Michael C O'Donovan,et al. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. , 2003, American journal of human genetics.
[3] N. Craddock,et al. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. , 2005, Schizophrenia bulletin.
[4] G. Kirov,et al. Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5 , 1999, Molecular Psychiatry.
[5] D. Housman,et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. , 1994, The Journal of nervous and mental disease.
[6] T. Kiviluoto,et al. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. , 1994, European Journal of Biochemistry.
[7] D. Weinberger,et al. The effect of apomorphine on regional cerebral blood flow in schizophrenia. , 1989, The Journal of neuropsychiatry and clinical neurosciences.
[8] Genetics of mood disorders , 2006 .
[9] J. Potash,et al. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. , 2002, The American journal of psychiatry.
[10] Steven P. Hamilton,et al. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22 , 2000, Biological Psychiatry.
[11] M. Rietschel,et al. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study , 2005, Molecular Psychiatry.
[12] G. Colditz,et al. Association between catechol-O-methyltransferase and phobic anxiety. , 2004, The American journal of psychiatry.
[13] Yufeng Wang,et al. Family‐based and case‐control association studies of catechol‐O‐methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[14] K K Kidd,et al. COMT haplotypes suggest P2 promoter region relevance for schizophrenia , 2004, Molecular Psychiatry.
[15] C. Mathews,et al. Meta‐analysis of the association between the catecholamine‐O‐methyl‐transferase gene and obsessive‐compulsive disorder , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[16] R Kucherlapati,et al. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? , 1996, The American journal of psychiatry.
[17] Abraham Weizman,et al. COMT: A common susceptibility gene in bipolar disorder and schizophrenia , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[18] M. Karayiorgou,et al. Effect of Dopamine Uptake Inhibition on Brain Catecholamine Levels and Locomotion in Catechol-O-methyltransferase-Disrupted Mice , 2002, Journal of Pharmacology and Experimental Therapeutics.
[19] K. Davis,et al. Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.
[20] J. Glowinski,et al. Selective activation of the mesocortical DA system by stress , 1976, Nature.
[21] P. Jensen. Catechol O-Methyltransferase Gene Variant and Birth Weight Predict Early-Onset Antisocial Behavior in Children With Attention-Deficit/Hyperactivity Disorder , 2007 .
[22] Paul J. Harrison,et al. Catechol-O-Methyltransferase Inhibition Improves Set-Shifting Performance and Elevates Stimulated Dopamine Release in the Rat Prefrontal Cortex , 2004, The Journal of Neuroscience.
[23] M. Owen,et al. Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. , 2005, Archives of general psychiatry.
[24] R. Weinshilboum,et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.
[25] T. Terao,et al. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics , 1998, Neuroscience Letters.
[26] R. Straub,et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] E S Lander,et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.
[28] N C Andreasen,et al. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow , 2005, Molecular Psychiatry.
[29] S. Faraone,et al. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. , 2003, The American journal of psychiatry.
[30] D. Weinberger,et al. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia , 2004, Trends in Neurosciences.
[31] W. Berrettini. Evidence for shared susceptibility in bipolar disorder and schizophrenia , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.
[32] P. Sham,et al. The future of association studies: gene-based analysis and replication. , 2004, American journal of human genetics.
[33] George C Patton,et al. Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health , 2005, Psychiatric genetics.
[34] Michael Knapp,et al. Impact of genotyping errors on type I error rate of the haplotype-sharing transmission/disequilibrium test (HS-TDT). , 2004, American journal of human genetics.
[35] Katherine M Kirk,et al. The impact of genotyping error on haplotype reconstruction and frequency estimation , 2002, European Journal of Human Genetics.
[36] Hie-Lim Kim,et al. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans , 2005, Human Genetics.
[37] R. Weinshilboum,et al. Thermal stability and the biochemical genetics of erythrocyte catechol‐O‐methyltransferase and plasma dopamine‐β‐hydroxylase , 1981, Clinical genetics.
[38] R Kucherlapati,et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. , 1996, American journal of medical genetics.
[39] C. Haynes,et al. Quantifying the Percent Increase in Minimum Sample Size for SNP Genotyping Errors in Genetic Model-Based Association Studies , 2005, Human Heredity.
[40] E. Gershon,et al. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia , 2002, Molecular Psychiatry.
[41] R. Shprintzen,et al. Late-onset psychosis in the velo-cardio-facial syndrome. , 1992, American journal of medical genetics.
[42] J. V. van Rossum. The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. , 1966, Archives internationales de pharmacodynamie et de therapie.
[43] A. Caspi,et al. Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction , 2005, Biological Psychiatry.
[44] A. Sazci,et al. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. , 2004, Brain research. Molecular brain research.
[45] R. Weksberg,et al. 22q11 deletion syndrome in adults with schizophrenia. , 1998, American journal of medical genetics.
[46] D. Clayton,et al. Population structure, differential bias and genomic control in a large-scale, case-control association study , 2005, Nature Genetics.
[47] M. Egan,et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.
[48] G. Kirov,et al. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. , 2005, Archives of general psychiatry.
[49] Jennifer H Barrett,et al. Association studies. , 2002, Methods in molecular biology.
[50] Elliot S. Gershon,et al. Genetic approaches to mental disorders , 1994 .
[51] A. Malhotra,et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.
[52] Birgit Funke,et al. COMT genetic variation confers risk for psychotic and affective disorders: a case control study , 2005, Behavioral and Brain Functions.
[53] Young-Hee Choi,et al. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. , 2004, Journal of psychiatric research.
[54] S. Ho,et al. Human catechol-O-methyltransferase down-regulation by estradiol , 2003, Neuropharmacology.
[55] Robert M Bilder,et al. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. , 2004, The American journal of psychiatry.
[56] D. Shields,et al. Preliminary evidence of an association between bipolar disorder in females and the catechol‐O‐methyltransferase gene , 1998, Psychiatric genetics.
[57] J. Ott,et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[58] D. Skuse,et al. COMT Val108/158Met Modifies Mismatch Negativity and Cognitive Function in 22q11 Deletion Syndrome , 2005, Biological Psychiatry.
[59] R. Ebstein,et al. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. , 1999, American journal of medical genetics.
[60] D. Skuse,et al. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. , 2005, Biological psychiatry.
[61] S. Ho,et al. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. , 1999, Molecular pharmacology.
[62] M. Owen,et al. A family based study of catechol‐O‐methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD) , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[63] Katharina Domschke,et al. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. , 2004, The international journal of neuropsychopharmacology.
[64] Leena Peltonen,et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.
[65] K. Kendler,et al. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families , 2004, Molecular Psychiatry.
[66] J. Duan,et al. Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia , 2005, Molecular Psychiatry.
[67] P. Sullivan,et al. Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. , 2002, The American journal of psychiatry.
[68] M. Owen,et al. Stressful life events, 5-HTT genotype and risk of depression , 2006, British Journal of Psychiatry.
[69] N. Craddock,et al. Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: Evidence, limitations, and implications , 2004 .
[70] K. Ohara,et al. Low activity allele of catechol‐o‐methyltransferase gene and Japanese unipolar depression , 1998, Neuroreport.
[71] D. Pfaff,et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[72] Allan I. Levey,et al. Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter , 1998, The Journal of Neuroscience.
[73] J. Beckmann,et al. A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.
[74] L. Epstein,et al. Catechol-O-Methyl-Transferase Functional Polymorphism and Nicotine Dependence: an Evaluation of Nonreplicated Results , 2005, Cancer Epidemiology Biomarkers & Prevention.
[75] D. Collier,et al. Catechol-O-methyltransferase Val158Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. , 1997, Pharmacogenetics.
[76] E. Zackai,et al. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. , 2004, The American journal of psychiatry.
[77] Francis J McMahon,et al. Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. , 2003, The American journal of psychiatry.
[78] N. Craddock,et al. Association studies of bipolar disorder. , 2001, Bipolar disorders.
[79] L. Fañanás,et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. , 2004, The American journal of psychiatry.
[80] David Goldman,et al. Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5′ nuclease assay , 2004, Psychopharmacology.
[81] M. Egan,et al. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications , 2004, Biological Psychiatry.
[82] A. Diamond,et al. Genetic and neurochemical modulation of prefrontal cognitive functions in children. , 2004, The American journal of psychiatry.
[83] R. Shprintzen,et al. Velo-cardio-facial syndrome: language and psychological profiles. , 1985, Journal of craniofacial genetics and developmental biology.
[84] H. Lachman,et al. Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele , 1998, Molecular Psychiatry.
[85] K. Devriendt,et al. Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. , 1997, Journal of medical genetics.
[86] Lin He,et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis , 2005, Biological Psychiatry.
[87] A. Reiss,et al. Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk , 2002, Biological Psychiatry.
[88] Alfredo Costa,et al. Multicentre Italian family‐based association study on tyrosine hydroxylase, catechol‐O‐methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders , 2003, Psychiatric genetics.
[89] Robin M. Murray,et al. No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene , 1997, Biological Psychiatry.
[90] Paul J. Harrison,et al. A novel protein isoform of catechol O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar disorder and effect of Val158Met genotype , 2006, Molecular Psychiatry.
[91] J. Axelrod,et al. Enzymatic O-methylation of epinephrine and other catechols. , 1958, The Journal of biological chemistry.
[92] R. Coppola,et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. , 2003, Archives of general psychiatry.
[93] J. Kelsoe,et al. Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder , 1997, Psychiatric genetics.
[94] Kenneth K Kidd,et al. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.
[95] G. Kirov,et al. No association between schizophrenia and polymorphisms in COMT in two large samples. , 2005, The American journal of psychiatry.
[96] Van Rossum Jm. The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. , 1966 .
[97] J. Lieberman,et al. Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia , 2002, Biological Psychiatry.
[98] M. Owen,et al. High rates of schizophrenia in adults with velo-cardio-facial syndrome (VCFS) , 1999, Schizophrenia Research.
[99] L. Wetterberg,et al. The Inheritance of human erythrocyte catechol‐O‐methyltransferase activity , 1981, Clinical genetics.
[100] Stephen J Finch,et al. What SNP genotyping errors are most costly for genetic association studies? , 2004, Genetic epidemiology.
[101] N. Craddock,et al. The beginning of the end for the Kraepelinian dichotomy , 2005, British Journal of Psychiatry.
[102] J. Ott,et al. Power and Sample Size Calculations for Case-Control Genetic Association Tests when Errors Are Present: Application to Single Nucleotide Polymorphisms , 2002, Human Heredity.
[103] D. Clayton,et al. Genome-wide association studies: theoretical and practical concerns , 2005, Nature Reviews Genetics.
[104] E. Zackai,et al. Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. , 1999, American journal of medical genetics.
[105] R. Shavitt,et al. Association analysis of the catechol‐o‐methyltransferase (COMT ), serotonin transporter (5‐HTT ) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive‐compulsive disorder , 2004, Genes, brain, and behavior.
[106] Stephan Eliez,et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome , 2005, Nature Neuroscience.
[107] N. Hayward,et al. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia , 2005, Molecular Psychiatry.
[108] M. Gill,et al. The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD , 2005, Experimental Brain Research.
[109] D. Jeffery,et al. Characterization of Membrane‐Bound and Soluble Catechol‐O‐Methyltransferase from Human Frontal Cortex , 1984, Journal of neurochemistry.
[110] N. Craddock,et al. The genetics of schizophrenia and bipolar disorder: dissecting psychosis , 2005, Journal of Medical Genetics.
[111] B. Gutiérrez,et al. Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. , 1997, The American journal of psychiatry.
[112] S. Klauck,et al. Haplotype analysis of the COMT‐ARVCF gene region in Israeli anorexia nervosa family trios , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[113] Shih-Jen Tsai,et al. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females , 2003, Neuroscience Letters.
[114] J. Callicott,et al. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. , 2004, The American journal of psychiatry.
[115] J P Boissel,et al. EasyMA: a program for the meta-analysis of clinical trials. , 1997, Computer methods and programs in biomedicine.
[116] Avshalom Caspi,et al. Strategy for investigating interactions between measured genes and measured environments. , 2005, Archives of general psychiatry.
[117] H. Hermesh,et al. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: A case–control study , 2005, Neuroscience Letters.
[118] M. Munafo,et al. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case–control studies , 2005, Molecular Psychiatry.
[119] G. Kirov,et al. No association between bipolar disorder and alleles at a functional polymorphism in the COMT gene , 1997, British Journal of Psychiatry.
[120] R. Murray,et al. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder , 1998, Molecular Psychiatry.
[121] C. Stefanis,et al. Variation in catechol-o-methyltransferase val158 met genotype associated with schizotypy but not cognition: A population study in 543 young men , 2004, Biological Psychiatry.
[122] T. Crow,et al. MECHANISM OF ACTION OF NEUROLEPTIC DRUGS , 1978, The Lancet.